Projects

International

• FP7 Health: Clinical Development of Nitisinone for Alkaptonuria
  Program: FP7
  Duration: 1. 11. 2012 – 31. 1. 2019

National

• Study of the possibilities and limitations of the implementation of modern genetic analyses in clinical diagnostic procedures in patients without a clear and unambiguous clinical diagnosis
  Program: VEGA
  Duration: 1. 1. 2024 – 31. 12. 2027

• Testing the effectiveness of polygenic risk score calculations from whole genome sequencing data and evaluation of hereditary patterns of polygenic diseases
  Program: VEGA
  Duration: 1. 1. 2023 – 31. 12. 2025

• Development and testing of molecular and informatic tools for effective characterisation and interpretation of clinically relevant microsatellite repetitive motifs from genomic data
  Program: SRDA
  Duration: 1. 7. 2019 – 30. 6. 2023

• Study of alternative ways of genome-wide polygenic risk score calculations for the estimation of individual genetic predispositions to complex multifactorial diseases
  Program: VEGA
  Duration: 1. 1. 2020 – 31. 12. 2022

• Study of the genetic background of variable severity of Alkaptonuria using genomic approach.
  Program: VEGA
  Duration: 1. 1. 2020 – 31. 12. 2022

• Implementation of modern genomic analyzes to improve clinical diagnostic and therapeutic procedures of Immune Disorders
  Program: Other projects
  Duration: 1. 12. 2018 – 31. 12. 2020

• Role of polysulfides in regulation of chloride channels and respiration of mitochondria
  Program: VEGA
  Duration: 1. 1. 2016 – 31. 12. 2018

• Study of the potential role of selected genes in molecular pathogenesis of myotonic dystrophy
  Program: VEGA
  Duration: 1. 1. 2015 – 31. 12. 2017